Table 1. Data of the 15 Patients With CEA Levels Available at the Time of Primary Tumour and Recurrence.
| Patient Demographics |
Primary Crc |
Recurrent Crcv | ||||
|---|---|---|---|---|---|---|
| Gender | Age | CEA | Location | Stage | CEA | Location |
| CEA normal primary CRC → CEA normal recurrent colorectal carcinoma | ||||||
| Male | 64 | 2.3 | High rectum | 3b | 7 | Liver |
| Male | 72 | 1 | Sigmoid | 2a | 1 | Liver |
| Female | 56 | 8 | High rectum | 2b | 2 | Pelvic wall |
| Male | 84 | 2 | Transverse colon | 3b | 4 | Brain, lungs |
| Male | 78 | 2 | Descending colon | 3c | 1 | Liver, spleen |
| Male | 70 | 3.4 | Caecum | 3b | 1 | Brain |
| Female | 77 | 3 | Sigmoid | 3c | 2 | Liver |
| CEA normal primary CRC → CEA elevated recurrent colorectal carcinoma | ||||||
| Male | 64 | 2.3 | Low rectum | 3b | 98 | Lung |
| Female | 80 | 1.6 | Caecum | 2b | 6.3* | Liver |
| Male | 69 | 1 | Low rectum | 2a | 52 | Local |
| Male | 80 | 1 | Low rectum | 2a | 17 | Liver |
| CEA elevated primary CRC → CEA elevated recurrent colorectal carcinoma | ||||||
| Female | 72 | 39.3 | Rectosigmoid | 3b | 180.9 | Liver |
| Male | 73 | 15 | Rectosigmoid | 3b | 11 | Liver, lung |
| Male | 73 | 211.8 | Transverse colon | 3c | 6975 | Lung |
| CEA elevated primary CRC → CEA normal recurrent colorectal carcinoma | ||||||
| Female | 60 | 14.4 | Caecum | 3b | 1 | Small bowel |
* The normal range for CEA was defined as < 5 µg/L by the laboratory in which this patient underwent her test as opposed to < 10 µg/L in the other patients.